Organocatalytic C─O Bond Cleavage and Asymmetric Transformations via [1,3]-Sigmatropic Rearrangement

Area of Science:

• Organic Chemistry
• Asymmetric Synthesis
• Medicinal Chemistry

Background:

• Chiral benzofuran derivatives are important scaffolds in medicinal chemistry.
• Efficient synthesis of molecules with quaternary carbon stereocenters remains a challenge.

Purpose of the Study:

• To develop a practical and atom-economic organocatalytic asymmetric [1,3]-sigmatropic rearrangement.
• To synthesize diverse chiral benzofuran derivatives with high stereoselectivity.
• To evaluate the potential anticancer activity of the synthesized compounds.

Main Methods:

• Organocatalytic asymmetric [1,3]-sigmatropic rearrangement involving C-O bond cleavage.
• Downstream transformations for product diversification.
• Enantioselectivity and diastereoselectivity analysis using chiral chromatography.
• Preliminary biological assays for anticancer activity.

Main Results:

• Successful synthesis of various chiral benzofuran derivatives bearing a quaternary carbon stereocenter.
• High yields (moderate to good) and excellent stereoselectivity (up to >99% ee and >99:1 d.r.).
• Initial biological tests indicate potential anticancer properties.

Conclusions:

• The reported organocatalytic method provides an efficient route to valuable chiral benzofurans.
• The synthesized enantioenriched benzofurans are promising candidates for anticancer drug development.